Publication: 3476

Publication: 3476

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 21 (8) 1431-9

Year:: 2003
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Marc L Citron Donald A Berry Constance Cirrincione Clifford Hudis Eric P Winer William J Gradishar Nancy E Davidson Silvana Martino Robert Livingston James N Ingle Edith A Perez John Carpenter David Hurd James F Holland Barbara L Smith Carolyn I Sartor Eleanor H Leung Jeffrey Abrams Richard L Schilsky Hyman B Muss Larry Norton

Networks:

Study: CALGB-9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Chemotherapy, Adjuvant, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Female, Filgrastim, Granulocyte Colony-Stimulating Factor, Humans, Middle Aged, Multivariate Analysis, Paclitaxel, Proportional Hazards Models, Recombinant Proteins, Survival Analysis, Treatment Outcome